GlassScriptPhysician profile
Heather B Pearman
NPI 1942263934
$4,892.58
in general payments reported to CMS, 2019-2025
22 companies · $599 in 2025
The $599 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $365 · 2021: $1,015 · 2022: $288 · 2023: $2,044 · 2024: $316 · 2025: $599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,671 · Travel and Lodging: $1,288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,670.56 |
| Travel and Lodging | $1,288.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $1,720.04 | 2023-2024 | |
| Horizon Therapeutics Plc | $1,264.85 | 2019-2021 | |
| Organogenesis INC. | $659.25 | 2019-2025 | Puraply, Novachor, Via Matrix |
| Smith+Nephew, INC. | $302.78 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium, Grafix |
| Averitas Pharma INC. | $280.72 | 2024-2025 | Qutenza |
| Paratek Pharmaceuticals, INC. | $132.46 | 2022-2025 | Nuzyra |
| Depuy Synthes Sales INC. | $97.90 | 2020-2023 | Motoband |
| Globus Medical, INC. | $74.44 | 2025 | Senza |
| Amgen INC. | $58.13 | 2024 | Krystexxa |
| Kci USA, INC. | $56.59 | 2020-2022 | |
| Stryker Corporation | $34.90 | 2020-2021 | |
| Abbvie INC. | $31.83 | 2024-2025 | |
| Lifenet Health | $29.46 | 2025 | Theragenesis Wound Matrix |
| Advanced Oxygen Therapy INC. | $24.78 | 2023-2025 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Solventum Corporation | $20.95 | 2024 | Activ.A.C. |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $19.49 | 2020 | |
| Tetraphase Pharmaceuticals, INC. | $16.94 | 2025 | |
| Integra Lifesciences Corporation | $15.45 | 2022 | |
| Grt US Holding, INC. | $15.12 | 2022 | |
| Bsn Medical INC | $12.74 | 2022 | |
| Hartmann USA, INC. | $12.14 | 2021 | |
| Kerecis Limited | $11.62 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Pearman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.